A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Gregory Y. Lip, Lars H. Rasmussen, Sol-Britt Olsson, Sofia Zetterstrand, Christina Stahre, Anders Bylock, Maria Aunes-Jansson, Karin Wahlander

Research output: Contribution to journalPublished meeting abstractpeer-review

Original languageEnglish
Pages (from-to)S1129-S1129
Issue number18
Publication statusPublished - 2009
Event82nd Scientific Session of the American-Heart-Association - Orlando, FL, United States
Duration: 2009 Nov 142009 Nov 18

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems

Cite this